Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.
BACKGROUND: Uncertainty persists concerning the effect of improved long-term glycemic control on macrovascular disease in diabetes mellitus (DM). METHODS: We performed a systematic review and meta-analysis of randomized controlled trials comparing interventions to improve glycemic control with conv...
Main Authors: | Stettler, C, Allemann, S, Jüni, P, Cull, C, Holman, R, Egger, M, Krähenbühl, S, Diem, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.
by: Cull, C, et al.
Published: (2007) -
A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
by: Holman, R, et al.
Published: (1999) -
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49)
by: Turner, R, et al.
Published: (1999) -
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
by: Turner, R, et al.
Published: (1999) -
Acarbose was effective in maintaining glycemic control in type 2 diabetes mellitus but was associated with adverse effects
by: Holman, R, et al.
Published: (1999)